The Institute of Medical Science, The University of Tokyo
Caption
Nafamostat, an existing safe drug, may inhibit entry of SARS-CoV-2.
Credit
Image: 2020 The University of Tokyo.
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.